Sunil Agarwal, Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 1,042 shares at $54.16 ($57K) on 2016-06-20, disclosed to the SEC on 2016-06-21.
Scheduled sale ($57k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.99 | 392 | $22K | 38.0% |
| 2 | $54.16 | 650 | $35K | 62.0% |
| Total | $54.47 avg | 1,042 | $57K | 100% |
| Filing → |
| RARE | SELL | 2016-07-21 | $34K | — | Filing → |
| RARE | SELL | 2016-05-26 | $43K | — | Filing → |
| RARE | SELL | 2016-04-21 | $46K | — | Filing → |